The global dengue diagnostics & treatment market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2021-2027). One of the most prevalent and commonly acknowledged procedures for detecting dengue fever is the enzyme-linked immunosorbent assay (ELISA). The test detects anti-DENV IgM or IgG antibodies in the patient’s serum. It is early and quick identification and treatment of dengue has the potential to lower the risk of severe dengue disease-related morbidity and mortality, as well as the danger of broader outbreaks. The usual approach for detecting NS1 antigens and differentiating between the four dengue virus serotypes is ELISA. When compared to other testing procedures, ELISA kits offer a higher sensitivity. When laboratories with experienced personnel and equipment are available, ELISAs have become the favored diagnostic method because to their great sensitivity and efficiency.
To Request a Sample of our Report on Global Dengue Diagnostics and Treatment Market: https://www.omrglobal.com/request-sample/dengue-diagnostics-and-treatment-market
The market is growing due to technological advancements in this category, such as robust test kits given by numerous leading competitors in the market. For instance, in 2019, Abbott’s PANBIO DENGUE IGG INDIRECT ELISA detected IgG antibodies to dengue antigen serotypes of 1, 2, 3, and 4 in serum as an assistance to clinical laboratory diagnosis of individuals with clinical symptoms and prior exposure consistent with dengue fever. DENV Detect NS1 ELISA Kit, which is likewise utilized for the early detection of dengue virus (DENV) NS1 antigen in human serum, is another test kit produced by In Bios International Inc. Thus, as a result of above stated factors, the market is likely to rise steadily over the forecast period (2021-2027).
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered
· Regions Covered– Globally
Competitive Landscape- including Corgenix Medical Corp, QuantuMDx Group Ltd., Quidel Corp, Sansure Biotech Inc., Whidiag SAS, Pictor Ltd. and others.
(Get 15% Discount on Buying this Report)
A full Report of Global Dengue Diagnostics and Treatment Market is Available at: https://www.omrglobal.com/industry-reports/dengue-diagnostics-and-treatment-market
Global Dengue Diagnostics & Treatment Market Report Segment
By Testing Type
• ELISA-Based Test
• RT-PCR Based Test
• Dengue IgG/IgM Rapid Test
• Others (Serologic and Tissue Test)
By Treatment
• Medication
• Supportive Care
• Vaccination
By End Users
• Hospitals & Clinics
• Diagnostic center
Global Dengue Diagnostics & Treatment Market Report Segment by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
Company Profiles
· Abnova
· Arkray Inc.
· Ceres Nanosciences Inc.
· Corgenix Medical Corp.
· FK-Biotecnologia SA
· InBios International Inc.
· Novatec immundiagnostica GmbH
· Origene Technologies
· PerkinElmer Inc.
· Pictor Ltd.
· QuantuMDx Group Ltd.
· Quidel Corporatation
· Sansure Biotech Inc.
· Whidiag SAS
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
